category
news
release
media
information
Announcement of Paper Publication: EditForce Demonstrated the Efficacy of a Treatment for Myotonic Dystrophy Type 1 Using PPR Platform Technology
COMPLETION OF FUND RAISING THROUGH THIRD-PARTY ALLOTMENT OF SHARES
ADOPTION OF AMED STRENGTHENING PROGRAM FOR PHARMACEUTICAL STARTUP ECOSYSTEM
FUND RAISING THROUGH THIRD-PARTY ALLOTMENT OF SHARES
EDITFORCE AND MITSUBISHI TANABE PHARMA ENTER INTO LICENSE AGREEMENT
EditForce completed fund raising by third-party allotment and AMED adopts our program
archive
All
Feel free to contact us when you have any questions or concerns.
